Across TCGA pan-cancer cohorts, KIF24 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KIF24 data layer compared with 30 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KIF24 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated KIF24 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and LSCC are the cancer types where KIF24 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.977	0.747	.009	38	view →
LSCC	DFS	Median	All	0.409	0.852	.009	14	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: KIF24 tumor-vs-normal RNA expression · all KIF24 data types